Desq Long
Sign in
SEC FORM 4
—

CRISPR Therapeutics AG (CRSP)

Acquisition (code M) of 2,113 shares; price not stated (see filing).

Reporting Person KASINGER JAMES R. · Officer Title General Counsel and Secretary · Transaction Code M

Traded Oct 13, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0001193125-26-423057 · filed 2026-10-15 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "CRISPR Therapeutics AG (CRSP)." Disclosed 2026-10-15. https://desqlong.com/cards/0001193125-26-423057-1 (retrieved 2026-10-16).